Pharmacological activation of the nuclear receptor REV-ERB reverses cognitive deficits and reduces amyloid-β burden in a mouse model of Alzheimer's disease
Deborah A. Roby, Fernanda Ruiz, Bailey A. Kermath, Jaymie R. Voorhees, Michael Niehoff, Jinsong Zhang, John E. Morley, Erik S. Musiek, Susan A. Farr, Thomas P. Burris
Dive into the research topics of 'Pharmacological activation of the nuclear receptor REV-ERB reverses cognitive deficits and reduces amyloid-β burden in a mouse model of Alzheimer's disease'. Together they form a unique fingerprint.